Form D · Pharmaceuticals
L.E.A.F. Pharmaceuticals LLC
Gulph Mills, PA · CIK 0001708743
Offering snapshot reported Aug 7, 2017 · SEC filing
- Reported sold
- $40.4M Offering amount: $40.4M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Aug 4, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 7, 2017 | Initial | $40,400,000 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-292251
Source: Form D, filed Aug 7, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Antoine Awad | Executive |
| Erin Friday | Executive |
| Mickey Gill | Executive |
| Victor Moyo | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
326 Overlook Lane
Gulph Mills, PA, 19428
Gulph Mills, PA, 19428